About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

National Diabetes Month: Your Eye Care Matters

Diabetes is a concerning health condition that affects nearly half of the adults in our country. When diabetes is a known health problem, proper eye care needs to take a place of priority. The fluctuations in blood sugar have a direct effect on overall eye health, affecting the integrity of ocular structures such as the […]

Posted on: Nov 9 2017
By: Saratoga Opthalmology

Recall: Midazolam injections recalled by Fresenius Kabi US

Due to a labeling error, Fresenius Kabi USA is voluntarily recalling lot 6400048 of Midazolam Injection, USP, 2 mg/2 mL. Source: AAO

Posted on: Nov 8 2017
By: Saratoga Opthalmology

Low-cost ziv-aflibercept appears safe for intraocular administration

A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent, is safe for treatment of retinal diseases. Source: AAO

Posted on: Nov 6 2017
By: Saratoga Opthalmology

Complement factor H carriers have larger drusen burden

This cross-sectional study describes the phenotypical characteristics of AMD patients carrying a rare variant in the complement factor H gene. Source: AAO

Posted on: Nov 6 2017
By: Saratoga Opthalmology

CXL effective for treating corneal ectasia after refractive surgery

This randomized sham-controlled trial evaluated the safety and efficacy of corneal crosslinking for patients who developed corneal ectasia after laser refractive surgery. Source: AAO

Posted on: Nov 6 2017
By: Saratoga Opthalmology

Dual-action glaucoma drops now approved in U.S.

The FDA has approved latanoprostene bunod (Vyzulta), a nitric oxide-donating prostaglandin analog, for reducing IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO